Largest Psychedelic Compound-Based Drug Stocks Up 14% MTD; Now Up 27% YTD

The psychedelic compound-based clinical stage drug research and development sector is Up 13.6% MTD and is now Up 26.6% YTD. This article analyzes the performance of the 6 largest stocks in the Psychedelic Drug Stocks Index over those two time periods in descending order.

  1. Seelos (SEEL): Up 31.7% MTD; Up 143.1% YTD
  2. Mind Medicine (MNMD): Up 30.3% MTD; Up 118.3% YTD
  3. Atai (ATAI): Up 21.5% MTD; Down 19.0% YTD
    • focused on the use of ketamine*, DMT* and ibogaine*.  Go here for much more extensive information on Ketamine and here for much more extensive information on DMT.
    • Market Capitalization: $347M
    • July 21st Stock Price: $2.09
    • current short interest: 3.4%
    • Read: Atai Life Sciences: Long On Money; Short On Success
  4. GH Research (GHRS): Up 10.4% MTD; Up 37.3% YTD
  5. Compass Pathways (CMPS): Up 8.2% MTD; Up 14.7% YTD
    • is focused on the use of psilocybin* (magic mushrooms) in their research. Go here for much more extensive information on Psilocybin and
    • Market Capitalization: $409M
    • July 21st Stock Price: $8.96
    • current short interest: 9.9% A high short interest signals that investors have become more bearish and may be getting ready to sell and, as such, that it may be time to liquidate a long position.
  6. Incannex Healthcare (IXHL): Up 7.7% MTD; Down 29.6% YTD
    • is researching and developing therapies and products with the world's largest portfolio of medicinal cannabinoid and psychedelic pharmaceutical products.
    • Market Capitalization: $117M (US)
    • July 21st Stock Price: $1.97
    • has announced that it intends to relocate to the United States, with plans to eventually delist from the ASX and switch to the NASDAQ board as it believes the US market is more receptive to pharmaceutical programs.
    • current short interest: NA
    • Read: Incannex Healthcare Has World's Largest Pipeline Of Psychedelic Products

*Read 10 Psychedelic Substances And The 36 Companies Researching Them for a description of each of the psychedelic-based compounds mentioned in this article.


The munKNEE Psychedelic Drug Stocks Index is Up 13.6% MTD and is now Up 26.6% YTD. If you are interested in this category, consider the  AdvisorShares Psychedelic ETF (PSIL) which consists of 23 such stocks. It is Up 8.2% MTD and is now Up 7.0% YTD.

More By This Author:

Largest Cannabis LPs Down 5% This Week
Largest Cannabis MSOs Down 8.5% So Far This Week
These 10 "Penny" AI Stocks Are Up 51% With Lots Of Room To Run

Disclosure: None

Visit and register to receive our free Market Intelligence Report newsletter (sample  more

How did you like this article? Let us know so we can better customize your reading experience.


Leave a comment to automatically be entered into our contest to win a free Echo Show.